Related Experiment Video
Updated: Aug 6, 2025

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation
Published on: November 8, 2013
Routine Rehabilitation as a Treatment Component for Patients With Pulmonary Arterial or Chronic Thromboembolic
Thomas Barret1, Bruno Degano, Hélène Bouvaist
1Service de Rééducation Cardiaque, Institut de Rééducation Sud, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France (Drs Barret, Noirclerc, and Rocca); Service de Cardiologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France (Drs Bouvaist and Vanzetto); Université Grenoble Alpes, Saint-Martin-d'Hères, France (Drs Degano, Pison, and Vanzetto); and Service Hospitalier Universitaire Pneumologie Physiologie, Pôle Thorax et Vaisseaux, CHU Grenoble Alpes, Grenoble, France (Drs Degano and Pison).
Supervised rehabilitation is safe and effective for patients with pulmonary hypertension (PH), improving exercise capacity and heart function. This approach enhances patient outcomes as part of multimodal treatment.
Area of Science:
- Cardiology
- Pulmonary Medicine
- Rehabilitation Medicine
Background:
- Historically, exercise was discouraged for pulmonary hypertension (PH) patients due to concerns about right-sided heart function.
- Current guidelines recognize the role of expert-center rehabilitation for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH).
- This study investigates the real-world effects of routine rehabilitation in PH patients receiving multimodal treatment.
Purpose of the Study:
- To evaluate the safety and efficacy of supervised rehabilitation as an adjunct therapy for patients with pulmonary hypertension (PH).
- To assess the impact of rehabilitation on clinical outcomes, including functional capacity, hemodynamics, and risk stratification in PAH and CTEPH patients.
Main Methods:
- Patients with PAH or CTEPH were enrolled in either inpatient or outpatient rehabilitation programs alongside usual care.
- Assessments included New York Heart Association (NYHA) class, adverse events, 6-minute walk test (6MWT), hemodynamics, and risk stratification.
- Data were collected from March 2010 to May 2019, including 41 patients.
Main Results:
- No major adverse events or deaths related to right-sided heart failure progression were reported.
- Rehabilitation significantly improved NYHA class (mean difference -0.39) and 6MWT distance (mean difference 80 m).
- Right-sided heart hemodynamics improved, and risk assessment grade decreased by -0.25 points post-rehabilitation.
Conclusions:
- Supervised rehabilitation is a safe and effective component of multimodal treatment for patients with PAH and CTEPH.
- Rehabilitation leads to significant improvements in patient functional capacity and clinical outcomes.
- This approach supports enhanced right-sided heart hemodynamics and reduced risk stratification in PH patients.
More Related Videos
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...

